Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
Targacept Inc. Identifier:
First received: February 9, 2011
Last updated: September 3, 2013
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 13, 2012